You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

9 articles

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Mar 2024

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Nov 2024

Comparison of PET/CT and PET/MR Imaging in Oncology

Document Status: Current
ID: ES PET 16
Version: 2

Apr 2024

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Jan 2024

Endometrial Cancer Molecular Testing Recommendations Report

Document Status: Current
Version: 1

Nov 2024

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Document Status: Current
Version: PET 2023-2

Jun 2024

Hereditary Cancer Testing Eligibility Criteria: Version 3.1

Document Status: Current
Version: 3.1

Oct 2024

Organizational Guidance for the Care of Patients with Central Nervous System Tumours in Ontario: Consensus Recommendations

Document Status: Current
ID: GL 9-11

Oct 2024

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Document Status: Current
Version: 2

Dec 2024